NIFTY 50

Wockhardt’s Khorakiwala: Manufacturing Oxford AstraZeneca COVID vaccine at UK plant; currently testing 2-3 million doses

Updated : December 31, 2020 09:59:51 IST

Wockhardt has initiated the manufacturing of Oxford AstraZeneca vaccine at its manufacturing plant in the UK, said Habil F Khorakiwala, Chairman and Group CEO of the pharma company on Thursday.

Speaking in an interview with CNBC-TV18, Khorakiwala said, “We have initiated the manufacturing of Oxford Astrazeneca vaccine in our manufacturing facility (UK plant) and about 2-3 million doses already manufactures and is waiting for testing.”

Wockhardt will be supplying 90-100 million doses as per its contract with the UK government, he added.

“We have manufactured about 2.5-3 million vaccines which is awaiting quality control check and once it is done by Astrazeneca, it will be released,” said Khorakiwala.

Khorakiwala said that his company would look to manufacture vaccine in India along with fill and finish.

“Our objective is to meet the needs of vaccine manufacturing.”

Watch the video for more
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you